ENCLEAR THERAPIES

enclear-therapies-logo

EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClearโ€™s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The companyโ€™s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).

#SimilarOrganizations #People #Financial #Website #More

ENCLEAR THERAPIES

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2018-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.encleartherapies.com

Total Employee:
1+

Status:
Active

Total Funding:
12 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business PHP Google Google Cloud


Similar Organizations

alios-biopharma-logo

Alios BioPharma

Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.

atalanta-therapeutics-logo

Atalanta Therapeutics

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

convalesce-logo

Convalesce

Stem Cell Based Therapy for Neurodegenerative diseases

currus-biologics-logo

Currus Biologics

Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

not_available_image

Genascence

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases

ray-therapeutics-logo

Ray Therapeutics

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

stalicla-logo

Stalicla

STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

jonathan-j-fleming_image

Jonathan J. Fleming Chairman Of The Board @ EnClear Therapies
Board_member
2018-06-01

kasper-roet_image

Kasper Roet Board member and Scientific Advisory Board member @ EnClear Therapies
Board_member
2018-01-01

Current Employees Featured

kevin-eggan_image

Kevin Eggan
Kevin Eggan Founder @ EnClear Therapies
Founder
2018-05-01

anthony-depasqua_image

Anthony DePasqua
Anthony DePasqua CEO & Co-Founder @ EnClear Therapies
CEO & Co-Founder
2018-06-01

Founder


anthony-depasqua_image

Anthony DePasqua

kevin-eggan_image

Kevin Eggan

kevin-eggan_image

Kevin Eggan

Investors List

dolby-family-ventures_image

Dolby Family Ventures

Dolby Family Ventures investment in Series A - EnClear Therapies

quark-venture_image

Quark Venture

Quark Venture investment in Series A - EnClear Therapies

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series A - EnClear Therapies

tachyon-ventures_image

Tachyon Ventures

Tachyon Ventures investment in Series A - EnClear Therapies

presight-capital_image

Presight Capital

Presight Capital investment in Series A - EnClear Therapies

20-20-healthcare-partners_image

20/20 HealthCare Partners

20/20 HealthCare Partners investment in Series A - EnClear Therapies

thiel-capital_image

Thiel Capital

Thiel Capital investment in Series A - EnClear Therapies

peter-thiel_image

Peter Thiel

Peter Thiel investment in Series A - EnClear Therapies

bioverge_image

Bioverge

Bioverge investment in Series A - EnClear Therapies

global-health-sciences-venture-fund_image

Global health sciences venture fund

Global health sciences venture fund investment in Series A - EnClear Therapies

Official Site Inspections

http://www.encleartherapies.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "EnClear Therapies"

About Us | EnClear Therapies

Our mission is to extend the lives of patients with CNS-related disease. Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation โ€ฆSee details»

EnClear Therapies - Crunchbase Company Profile

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative diseaseSee details»

EnClear Therapies - LinkedIn

EnClear Therapies | 1,169 followers on LinkedIn. CSF based Therapies, Delivery and Diagnostics | At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop โ€ฆSee details»

EnClear Therapies - 2025 Company Profile & Team - Tracxn

Jul 17, 2025 Explore EnClear Therapies' in-depth company profile, including funding details, key investors, leadership, and competitors.See details»

EnClear Therapies Company Profile - Office Locations ... - Craft

EnClear Therapies has 5 employees at their 1 location and $12 m in total funding,. See insights on EnClear Therapies including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

EnClear Therapies - Overview, News & Similar companies

Feb 19, 2020 View EnClear Therapies (www.encleartherapies.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โ€ฆSee details»

EnClear Therapies: Revenue, Worth, Valuation & Competitors 2025

About EnClear Therapies EnClear Therapies is a Medical Equip related company founded in 2018 and based in Newburyport with 12 employees an estimated revenue of $3.3M, and. It has 10 โ€ฆSee details»

EnClear Therapies Company Overview, Contact Details

Learn more about EnClear Therapies's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

EnClear Therapies 2025 Company Profile: Valuation, โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for EnClear Therapies. Use the PitchBook Platform to explore the full profile.See details»

Home | EnClear Therapies

At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business utilizing our proprietary EnTrega CSF โ€ฆSee details»

Enclear Therapies, Inc. - Drug pipelines, Patents, Clinical trials ...

May 8, 2025 Explore Enclear Therapies, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»

EnClear Therapies - VentureRadar

Develops innovative biomedical technologies for controlled access, delivery, and modification of cerebrospinal fluid to treat neurodegenerative diseases in genetically defined patient โ€ฆSee details»

EnClear Therapies - Executive Bio, Top Executies, and Transitions ...

View the organization profile of EnClear Therapies,EnClear Therapies ' Top Executives Anthony R. DePasqua MBA Co-Founder, Chief Executive Officer & Director 20+ years leading product โ€ฆSee details»

The EnClear Team | EnClear Therapies

Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.See details»

EnClear Therapies - Profiles & Contacts - Crunchbase

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative diseaseSee details»

PROGRAMS - EnClear Therapies

Efficiently move to market & help patients with internal programs. Technology validation & new market expansion through partnerships.See details»

EnClear Therapies - VentureRadar

Associated sectors: Biotechnology; Biotech; Medical Devices; Health; BioRelax Unknown Privately Held BioRelax® with Kleinsche fields offers innovative, registered Class 1 medical โ€ฆSee details»

Advisors & Collaborators - EnClear Therapies

Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.See details»

News - EnClear Therapies

Jun 8, 2021 Heather Gray-Edwards discusses Next Generation CNS Delivery at the 3rd Annual Gene Therapy for Neurological Disorders this week in Boston. EnClear Therapies is proud to โ€ฆSee details»

Contact - EnClear Therapies

11/14/2023: Please be advised that the company has not sent any job offers. Any contact regarding jobs at EnClear Therapies as of today are false.See details»

linkstock.net © 2022. All rights reserved